Helix 12 directed steroidal pharmaceutical products

Details for Australian Patent Application No. 2009202038 (hide)

Owner Endorecherche, Inc.

Inventors Singh, Shankar; Gauthier, Sylvain; Chenard, Sylvain; Labrie, Fernand; Frechette, Yvon; Breton, Rock

Agent Griffith Hack

Pub. Number AU-A-2009202038

Parent 2005203922

Filing date 22 May 2009

Wipo publication date 11 June 2009

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 35/00 (2006.01) Antineoplastic agents

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

11 June 2009 Application Open to Public Inspection

  Published as AU-A-2009202038

11 June 2009 Complete Application Filed

6 August 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 Jul 2009

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202039-Arrangement on a cableway for detecting incorrect positioning of a carrying cable

2009202037-A gaming system and method of gam- ing